Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P53675 (
CHC22
)
19
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In humans, there are two isoforms each of clathrin heavy chain (CHC17 and
CHC22
) and light chain (LCa and LCb) subunits, all encoded by separate genes. CHC17 forms the ubiquitous clathrin-coated vesicles that mediate membrane traffic.
CHC22
is implicated in specialized membrane organization in skeletal muscle. CHC17 is bound and regulated by LCa and LCb, whereas
CHC22
does not functionally interact with either light chain. The imbalanced interactions between clathrin subunit isoforms suggest a distinct evolutionary history for each isoform pair. Phylogenetic and sequence analysis placed both heavy and light chain gene duplications during chordate evolution, 510-600 million years ago. Genes encoding
CHC22
orthologues were found in several vertebrate species, with only a pseudogene present in mice. Multiple paralogons surrounding the CHC genes (
CLTC
and CLTD) were identified, evidence that genomic or large-scale gene duplication produced the two CHC isoforms. In contrast, clathrin light chain genes (CLTA and CLTB) apparently arose by localized duplication, within 1-11 million years of CHC gene duplication. Analysis of sequence divergence patterns suggested that structural features of the CHCs were maintained after gene duplication, but new interactions with regulatory proteins evolved for the
CHC22
isoform. Thus, independent mechanisms of gene duplication expanded clathrin functions, concomitant with development of neuromuscular sophistication in chordates.
...
PMID:Clathrin heavy and light chain isoforms originated by independent mechanisms of gene duplication during chordate evolution. 1588 69
CHC22
clathrin plays a key role in intracellular membrane traffic of the insulin-responsive glucose transporter GLUT4 in humans. We performed population genetic and phylogenetic analyses of the
CHC22
-encoding
CLTCL1
gene, revealing independent gene loss in at least two vertebrate lineages, after arising from gene duplication. All vertebrates retained the paralogous
CLTC
gene encoding CHC17 clathrin, which mediates endocytosis. For vertebrates retaining
CLTCL1
, strong evidence for purifying selection supports
CHC22
functionality. All human populations maintained two high frequency
CLTCL1
allelic variants, encoding either methionine or valine at position 1316. Functional studies indicated that
CHC22
-V1316, which is more frequent in farming populations than in hunter-gatherers, has different cellular dynamics than M1316-
CHC22
and is less effective at controlling GLUT4 membrane traffic, altering its insulin-regulated response. These analyses suggest that ancestral human dietary change influenced selection of allotypes that affect
CHC22
's role in metabolism and have potential to differentially influence the human insulin response.
...
PMID:Genetic diversity of CHC22 clathrin impacts its function in glucose metabolism. 3115 24